NIDDK Central Repository - Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection.

An official website of the United States government

NIDDK Central Repository

Publication Information

DOI

10.1016/j.cgh.2008.02.035

PubMed ID

18407798

Public Release Type

Journal

Publication Year

2008

Affiliation

University of Maryland Baltimore School of Medicine, Baltimore, Maryland 21201, USA. chowell@umaryland.edu

Authors

Dowling TC, Hoofnagle JH, Howell CD, Jeffers L, Paul M, Taylor M, Terrault NA, Virahep-C Study Group, Wahed AS

Studies

Virahep-C

Citation

Howell CD, Dowling TC, Paul M, Wahed AS, Terrault NA, Taylor M, Jeffers L, Hoofnagle JH, Virahep-C Study Group. Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection. Clin Gastroenterol Hepatol 2008 May;6(5):575-83. Epub 2008 Apr 14.

Abstract

The relationship between serum peginterferon pharmacokinetics and pharmacodynamics and the early virologic response (EVR) to peginterferon and ribavirin therapy was assessed in patients with chronic hepatitis C virus (HCV) genotype 1 infection.